Chugai Pharmaceutical Co Ltd CHGCY
$22.19 $0.10 (0.45%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
CHGCY Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Chugai Pharmaceutical Co Ltd is classified as halal.
HALAL
Report Source: undefined Quarter Report
Chugai Pharmaceutical Co Ltd. Stock Analysis CHGCY
United States Health Care Large Cap Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 7,872 full-time employees. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The firm is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The firm operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.
Chugai Pharmaceutical Co Ltd (CHGCY) Chart
Financial Metrics & Statements of Chugai Pharmaceutical Co Ltd (CHGCY)
FAQ's for Chugai Pharmaceutical Co Ltd (CHGCY)
- As of August 2026, Chugai Pharmaceutical Co Ltd CHGCY is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Chugai Pharmaceutical Co Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Chugai Pharmaceutical Co Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Chugai Pharmaceutical Co Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Chugai Pharmaceutical Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Chugai Pharmaceutical Co Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Chugai Pharmaceutical Co Ltd (CHGCY)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
